JP2002527414A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527414A5
JP2002527414A5 JP2000575820A JP2000575820A JP2002527414A5 JP 2002527414 A5 JP2002527414 A5 JP 2002527414A5 JP 2000575820 A JP2000575820 A JP 2000575820A JP 2000575820 A JP2000575820 A JP 2000575820A JP 2002527414 A5 JP2002527414 A5 JP 2002527414A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
hydrogen
substituted
iodo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000575820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002527414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/023779 external-priority patent/WO2000021910A2/en
Publication of JP2002527414A publication Critical patent/JP2002527414A/ja
Publication of JP2002527414A5 publication Critical patent/JP2002527414A5/ja
Pending legal-status Critical Current

Links

JP2000575820A 1998-10-14 1999-10-13 1,2−ジ置換シクロプロパン Pending JP2002527414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10413298P 1998-10-14 1998-10-14
US60/104,132 1998-10-14
PCT/US1999/023779 WO2000021910A2 (en) 1998-10-14 1999-10-13 1,2-disubstituted cyclopropanes

Publications (2)

Publication Number Publication Date
JP2002527414A JP2002527414A (ja) 2002-08-27
JP2002527414A5 true JP2002527414A5 (enExample) 2006-12-21

Family

ID=22298823

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000575820A Pending JP2002527414A (ja) 1998-10-14 1999-10-13 1,2−ジ置換シクロプロパン

Country Status (5)

Country Link
US (1) US6172091B1 (enExample)
JP (1) JP2002527414A (enExample)
AU (1) AU760889B2 (enExample)
CA (1) CA2347092A1 (enExample)
WO (1) WO2000021910A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809396B1 (fr) * 2000-05-24 2005-10-14 Centre Nat Rech Scient Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
US6908935B2 (en) 2002-05-23 2005-06-21 Amgen Inc. Calcium receptor modulating agents
US7176322B2 (en) * 2002-05-23 2007-02-13 Amgen Inc. Calcium receptor modulating agents
EP1663182B2 (en) 2003-09-12 2019-11-20 Amgen Inc. RAPID DISSOLUTION FORMULATION OF CINACALCET HCl
WO2005065050A2 (ja) 2003-12-25 2005-07-21 Asahi Kasei Pharma Corporation 2環化合物
ES2561111T3 (es) 2004-05-28 2016-02-24 Mitsubishi Tanabe Pharma Corporation Arilalquilaminas y procedimiento para la producción de las mismas
AP2007004157A0 (en) 2005-03-17 2007-10-31 Pfizer N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
MX2007011153A (es) * 2005-03-17 2007-12-12 Amgen Inc Metodos para reducir la calcificacion.
CA2645494C (en) * 2006-03-23 2016-01-12 Amgen Inc. Methods and compositions for making and using polymorphs of cinacalcet
EP2010150A2 (en) * 2006-04-20 2009-01-07 Amgen Inc. Stable emulsion formulations
EP2021747B1 (en) * 2006-04-26 2018-08-01 Halliburton Energy Services, Inc. Fiber optic mems seismic sensor with mass supported by hinged beams
US8093299B2 (en) 2007-03-30 2012-01-10 Amgen Inc. Methods of treating bowel disorders
WO2010104882A1 (en) 2009-03-10 2010-09-16 Amgen Inc. Methods of modulating sperm motility
EP2435400A2 (en) 2009-05-27 2012-04-04 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
EP2435404A1 (en) 2009-05-27 2012-04-04 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
US8497271B2 (en) * 2009-10-07 2013-07-30 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
RU2599789C2 (ru) 2010-06-30 2016-10-20 Лео Фарма А/С Новая полиморфная форма кальцимиметического соединения
RU2599788C2 (ru) 2010-06-30 2016-10-20 Лео Фарма А/С Новая полиморфная форма кальцимиметического соединения
EP2643298A1 (en) 2010-11-26 2013-10-02 Leo Pharma A/S Substituted cyclopentyl - azines as casr- active compounds
JP2014508104A (ja) 2010-11-26 2014-04-03 レオ ファーマ アクティーゼルスカブ カルシウム感知受容体活性化合物
WO2012069419A1 (en) 2010-11-26 2012-05-31 Leo Pharma A/S Calcium-sensing receptor-active compounds
RU2013128973A (ru) 2010-11-26 2015-01-10 Лео Фарма А/С Соединения, активные в отношении кальций-чувствительных рецепторов
CN104837811A (zh) * 2012-12-10 2015-08-12 H.隆德贝克有限公司 烟碱乙酰胆碱受体的新的正向別构调节剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802981A1 (de) 1988-02-02 1989-08-10 Basf Ag Verfahren zur reduktion reduzierbarer verbindungen
FR2636625B1 (fr) 1988-09-01 1990-11-09 Jouveinal Sa Benzylamines disubstituees, leur procede de preparation, leur utilisation comme medicament et leurs intermediaires de synthese
US5169780A (en) 1989-06-22 1992-12-08 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
ES2256370T3 (es) 1991-08-23 2006-07-16 Nps Pharmaceuticals, Inc. Moleculas activas para el receptor de calcio.
US6071970A (en) 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69333527T2 (de) 1993-02-23 2005-06-16 Brigham & Women's Hospital, Inc., Boston Calciumrezeptoraktive moleküle
PT743853E (pt) 1994-02-08 2001-10-31 Nps Pharma Inc Compostos activos num novo local em canis de calcio activados por um receptor uteis para o tratamento de perturbacoes e doencas neurologicas
US5504253A (en) 1994-07-15 1996-04-02 Nps Pharmaceuticals, Inc. Amine preparation
AU3414295A (en) 1994-08-19 1996-03-14 Nps Pharmaceuticals, Inc. Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases
CN1147459C (zh) 1994-10-21 2004-04-28 Nps药物有限公司 钙受体活性化合物
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CA2176854A1 (en) 1995-06-07 1996-12-08 Daniel J. Keavy N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics

Similar Documents

Publication Publication Date Title
JP2002527414A5 (enExample)
JP2002030084A5 (enExample)
JP2003519676A5 (enExample)
JP2004516314A5 (enExample)
JP2007510619A5 (enExample)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
JP2007520440A5 (enExample)
JP2002541233A5 (enExample)
JP2003531118A5 (enExample)
JP2004505047A5 (enExample)
JP2008511601A5 (enExample)
JP2002540208A5 (enExample)
JP2004500426A5 (enExample)
JP2005526836A5 (enExample)
JP2004533444A5 (enExample)
JP2007530694A5 (enExample)
NZ515282A (en) Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
JP2005511547A5 (enExample)
JP2002518502A5 (enExample)
JP2002520316A5 (enExample)
JP2005539045A5 (enExample)
JP2003502367A5 (enExample)
JP2006504738A5 (enExample)
JP2004532185A5 (enExample)
JP2004525184A5 (enExample)